Josefa Zaldívar-Díez

Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors

Annachiara Gandini, Manuela Bartolini, Daniele Tedesco et al. · Journal of Medicinal Chemistry · 2018 · 102 citations · Full text

Classics in Chemical Neuroscience: Haloperidol

Marshall Tyler, Josefa Zaldívar-Díez, Stephen J. Haggarty · ACS Chemical Neuroscience · 2017 · 69 citations

Facilitated Deinstitutionalization, Psychopharmacology, Social Sciences +17

Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa

Alonso Sánchez-Cruz, Beatriz Villarejo‐Zori, Miguel Marchena et al. · Molecular Neurodegeneration · 2018 · 40 citations · Full text

Leucine rich repeat kinase 2 (LRRK2) inhibitors based on indolinone scaffold: Potential pro-neurogenic agents

Irene G. Salado, Josefa Zaldívar-Díez, Víctor Sebastián-Pérez et al. · European Journal of Medicinal Chemistry · 2017 · 34 citations · Full text

Potential Pro-neurogenic Agents, Medicine, Pharmacological Agent +9

Small molecules targeting glycogen synthase kinase 3 as potential drug candidates for the treatment of retinitis pigmentosa

Miguel Marchena, Beatriz Villarejo‐Zori, Josefa Zaldívar-Díez et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2017 · 25 citations · Full text

Glycogen Synthase, Ocular Disease, Cell Regulation +15